Inhibitory effect of 2-methyl-naphtho[1,2,3-de]quinolin-8-one on melanosome transport and skin pigmentation

Citations Over TimeTop 21% of 2016 papers

Abstract

Melanosomes are lysosome-related organelles with specialized capabilities of melanin synthesis and movement mediated by the Rab27a-Melanophilin-MyosinVa protein complex. In this study, we found that 2-methyl-naphtho[1,2,3-de]quinolin-8-one (MNQO) induced melanosome aggregation around the nucleus in melan-a melanocytes and in melan-a melanocytes/SP-1 keratinocyte co-cultures without inducing toxicity or changing the melanin content. Western blot and real-time PCR analyses showed that MNQO decreased expression of the Rab27a, Melanophilin and MyosinVa proteins and mRNAs, respectively, in melan-a melanocytes. In a reconstituted human epidermis model, treatment with 0.001% MNQO reduced skin pigmentation. Also, MNQO reduced skin pigmentation in brown guinea pigs induced by UVB irradiation. These results indicated that regulation of melanosome transport may serve as a good target for new skin depigmenting agents and MNQO itself could be a candidate.

Related Papers

• → Mimicking Melanosomes: Polydopamine Nanoparticles as Artificial Microparasols(2017)161 cited
• Characterization of melanogenesis and morphogenesis of melanosomes by physicochemical properties of melanin and melanosomes in malignant melanoma.(1984)
• → Dynamic visualization of melanosome endo/phagocytosis during melanin transfer using melanosomes pre-stained with carbocyanine dyes(2021)4 cited
• → The Site of Biosynthesis of Mammalian Tyrosinase11From the Research Laboratories of the Department of Dermatology of the Harvard Medical School at the Massachusetts General Hospital, Boston 14, Massachusetts and The Chester Beatty Research Institute, Institute of Cancer Research, Royal Cancer Hospital, London, S.W.3, England.This work was supported by Grant #CY-5010 of the National Institutes of Health, U.S. Public Health Service, Department of Health, Education and Welfare and by Grant 257-E of the Damon Runyon Memorial Fund for Cancer Research, Inc.Presented at the Twenty-second Annual Meeting of The Society for Investigative Dermatology, Inc., New York, N.Y., June 27, 1961.(1961)14 cited
• → Amelanotic malignant melanoma: recognizing aberrant premelanosomes(1995)